|
ST13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.60379999783567E-08 |
| Normal-vs-Stage3 |
4.36439999695892E-08 |
| Normal-vs-Stage4 |
5.45190000034168E-07 |
| Stage1-vs-Stage2 |
1.463950E-01 |
| Stage1-vs-Stage3 |
1.334760E-01 |
| Stage1-vs-Stage4 |
6.691800E-01 |
| Stage2-vs-Stage3 |
9.572400E-01 |
| Stage2-vs-Stage4 |
5.142800E-01 |
| Stage3-vs-Stage4 |
6.360600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.24809060256348E-12 |
| Normal-vs-Asian |
9.116400E-02 |
| Caucasian-vs-AfricanAmerican |
7.112000E-01 |
| Caucasian-vs-Asian |
8.941200E-01 |
| AfricanAmerican-vs-Asian |
8.562600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.71018754713259E-12 |
| Male-vs-Female |
1.870580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66533453693773E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
3.74145159298678E-14 |
| Normal-vs-Extreme_Obese |
1.04619999996558E-06 |
| Normal_Weight-vs-Extreme_Weight |
6.689200E-01 |
| Normal_Weight-vs-Obese |
3.275200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.223600E-01 |
| Extreme_Weight-vs-Obese |
1.162400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.580400E-01 |
| Obese-vs-Extreme_Obese |
8.253200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.05959996122129E-09 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.50490000017101E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.972400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.828000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.403200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.827400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.050000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.291000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
6.62560006858826E-11 |
| Normal-VS-KIRP CIMP |
1.62820000004782E-06 |
| Normal-VS-Unclassified PRCC |
3.29725136083425E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.471980E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.998400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.241400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.977800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.161200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.814600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.98205904414317E-13 |
| Normal-vs-N1 |
4.50000003926476E-09 |
| Normal-vs-N2 |
5.418300E-03 |
| N0-vs-N1 |
3.283200E-01 |
| N0-vs-N2 |
4.303000E-01 |
| N1-vs-N2 |
7.046600E-01 |
|
|
